• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佐剂在黏膜疫苗研发中的作用。

The role of adjuvants in the development of mucosal vaccines.

作者信息

Vajdy Michael, Singh Manmohan

机构信息

Chiron Vaccines, 4560 Horton Street, Emeryville, California 94608, USA.

出版信息

Expert Opin Biol Ther. 2005 Jul;5(7):953-65. doi: 10.1517/14712598.5.7.953.

DOI:10.1517/14712598.5.7.953
PMID:16018740
Abstract

It is well-established that most pathogens that cause infectious diseases enter the host via mucosal membranes of the respiratory, digestive and genital tracts. Some parenterally administered vaccines induce protection against mucosal pathogens. However, there is increasing evidence that mucosal protection is better afforded by mucosal vaccination, particularly for the induction of memory responses. Mucosal vaccines must pass several difficult hurdles before entering the host and inducing an effective and protective immune response. This review deals with present and past efforts in devising effective mucosal vaccines using delivery systems and immunopotentiating adjuvants for protein-based vaccines. The paper will conclude with the authors' opinion on how the field will or should progress in the future and what will be the required components of ideal future mucosal vaccines that can induce immunological memory.

摘要

众所周知,大多数引起传染病的病原体是通过呼吸道、消化道和生殖道的粘膜进入宿主的。一些通过非肠道途径给药的疫苗可诱导针对粘膜病原体的保护作用。然而,越来越多的证据表明,粘膜疫苗接种能更好地提供粘膜保护,特别是对于诱导记忆反应而言。粘膜疫苗在进入宿主并诱导有效和保护性免疫反应之前必须克服几个困难障碍。本综述探讨了过去和目前在设计有效的粘膜疫苗方面所做的努力,这些努力涉及使用递送系统和免疫增强佐剂来研发基于蛋白质的疫苗。本文将以作者对该领域未来将如何或应该取得进展的看法作为结尾,并阐述理想的未来粘膜疫苗为诱导免疫记忆所需的组成部分。

相似文献

1
The role of adjuvants in the development of mucosal vaccines.佐剂在黏膜疫苗研发中的作用。
Expert Opin Biol Ther. 2005 Jul;5(7):953-65. doi: 10.1517/14712598.5.7.953.
2
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.基于霍乱毒素、霍乱毒素B亚基和CpG DNA的黏膜佐剂以及抗感染和抗免疫病理疫苗。
Expert Rev Vaccines. 2003 Apr;2(2):205-17. doi: 10.1586/14760584.2.2.205.
3
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.黏膜疫苗:作为黏膜佐剂的LT和CT无毒衍生物。
Vaccine. 2001 Mar 21;19(17-19):2534-41. doi: 10.1016/s0264-410x(00)00553-3.
4
Mucosal delivery of vaccines.
Methods. 1999 Sep;19(1):148-55. doi: 10.1006/meth.1999.0840.
5
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.基于霍乱毒素、霍乱毒素B亚基和CpG DNA的黏膜佐剂以及抗感染和抗免疫病理疫苗。
Immunol Lett. 2005 Mar 15;97(2):181-8. doi: 10.1016/j.imlet.2004.11.009. Epub 2004 Dec 7.
6
An enzymatically active a domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: new method for screening mucosal adjuvants.霍乱样肠毒素诱导口服耐受产生长期阻断作用需要具有酶活性的A亚基:一种筛选黏膜佐剂的新方法。
Infect Immun. 2003 Dec;71(12):6850-6. doi: 10.1128/IAI.71.12.6850-6856.2003.
7
Determining the activity of mucosal adjuvants.确定黏膜佐剂的活性。
Methods Mol Biol. 2010;626:261-85. doi: 10.1007/978-1-60761-585-9_18.
8
Cytokines: the future of intranasal vaccine adjuvants.细胞因子:鼻内疫苗佐剂的未来
Clin Dev Immunol. 2011;2011:289597. doi: 10.1155/2011/289597. Epub 2011 Jul 31.
9
Immunomodulation using bacterial enterotoxins.使用细菌肠毒素进行免疫调节。
Scand J Immunol. 2001 Mar;53(3):218-26. doi: 10.1046/j.1365-3083.2001.00884.x.
10
Mucosal vaccine design and delivery.黏膜疫苗的设计与递送。
Annu Rev Biomed Eng. 2012;14:17-46. doi: 10.1146/annurev-bioeng-071811-150054. Epub 2012 Apr 18.

引用本文的文献

1
A Poly-Lysine-Based RBD Mucosal Vaccine Induces Potent Antibody Responses in Mice.一种基于聚赖氨酸的RBD粘膜疫苗在小鼠中诱导出强效抗体反应。
Vaccines (Basel). 2025 May 29;13(6):582. doi: 10.3390/vaccines13060582.
2
Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Enterotoxin.无佐剂双价食源性致病菌疫苗的研制:增强肠毒素抗原性。
Front Immunol. 2018 Oct 9;9:2320. doi: 10.3389/fimmu.2018.02320. eCollection 2018.
3
Effect of vaccine administration modality on immunogenicity and efficacy.
疫苗接种方式对免疫原性和疗效的影响。
Expert Rev Vaccines. 2015;14(11):1509-23. doi: 10.1586/14760584.2015.1081067. Epub 2015 Aug 27.
4
Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.纳米乳剂鼻内佐剂的配方与表征:表面活性剂组成对粘膜粘附性和免疫原性的影响
Mol Pharm. 2014 Feb 3;11(2):531-44. doi: 10.1021/mp4005029. Epub 2013 Dec 13.
5
Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.新型佐剂人类免疫缺陷病毒 1 型疫苗制剂初免-加强免疫后诱导黏膜和系统抗体及 T 细胞应答。
J Gen Virol. 2011 Jan;92(Pt 1):128-40. doi: 10.1099/vir.0.023242-0.